A detailed history of Cetera Investment Advisers transactions in Novo Nordisk A S stock. As of the latest transaction made, Cetera Investment Advisers holds 290,845 shares of NVO stock, worth $34.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
290,845
Previous 265,538 9.53%
Holding current value
$34.3 Million
Previous $34.1 Million 21.76%
% of portfolio
0.1%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

BUY
$122.71 - $146.91 $3.11 Million - $3.72 Million
25,307 Added 9.53%
290,845 $41.5 Million
Q1 2024

May 24, 2024

BUY
$102.11 - $135.92 $23.9 Million - $31.9 Million
234,530 Added 756.35%
265,538 $34.1 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $1.73 Million - $2.31 Million
-16,985 Reduced 35.39%
31,008 $3.98 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $236,391 - $283,976
2,693 Added 5.94%
47,993 $4.96 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $2.14 Million - $4.69 Million
23,489 Added 107.69%
45,300 $4.12 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $145,997 - $161,600
936 Added 4.48%
21,811 $3.53 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $55,582 - $66,838
-420 Reduced 1.97%
20,875 $3.32 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $732,719 - $966,932
7,145 Added 50.49%
21,295 $2.88 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $222,383 - $272,914
-2,334 Reduced 14.16%
14,150 $1.41 Million
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $374,554 - $441,926
3,628 Added 28.22%
16,484 $1.84 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $40,312 - $48,729
-433 Reduced 3.26%
12,856 $1.43 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $27,038 - $33,016
282 Added 2.17%
13,289 $1.49 Million
Q3 2021

Nov 16, 2021

BUY
$84.42 - $106.62 $126,123 - $159,290
1,494 Added 12.98%
13,007 $1.25 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $70,434 - $88,235
1,041 Added 9.94%
11,513 $964,000
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $123,591 - $139,736
-1,843 Reduced 14.97%
10,472 $706,000
Q4 2020

Feb 17, 2021

BUY
$63.89 - $73.8 $402,379 - $464,792
6,298 Added 104.67%
12,315 $860,000
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $169,861 - $187,276
2,667 Added 79.61%
6,017 $418,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $310,496 - $360,353
-5,304 Reduced 61.29%
3,350 $219,000
Q1 2020

May 08, 2020

SELL
$49.46 - $64.78 $10,534 - $13,798
-213 Reduced 2.4%
8,654 $521,000
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $27,123 - $31,693
544 Added 6.54%
8,867 $514,000
Q3 2019

Nov 06, 2019

BUY
$47.54 - $53.43 $114,951 - $129,193
2,418 Added 40.95%
8,323 $431,000
Q2 2019

Aug 12, 2019

SELL
$46.79 - $52.47 $16,282 - $18,259
-348 Reduced 5.57%
5,905 $300,000
Q1 2019

May 06, 2019

SELL
$46.36 - $52.63 $6,258 - $7,105
-135 Reduced 2.11%
6,253 $326,000
Q4 2018

Feb 15, 2019

BUY
$41.54 - $47.25 $30,282 - $34,445
729 Added 12.88%
6,388 $295,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $264,614 - $289,967
5,659 New
5,659 $268,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $266B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.